Analysis

European Cannabis Stocks Review: SEED Innovations Shares Spike 25%, Futura Medical Signs Commercialisation Deal, & More From Akanda

AS quarterly and full-year results continued to be published across the global cannabis industry, European stocks enjoyed a relatively stable week compared to their...

European Cannabis Stocks Roundup: Aurora Stocks Jump On EU Medical Market Growth Despite $1bn Loss

IT'S been a jam-packed week for the global cannabis industry as a host of companies including Aurora, Halo Collective, Dancann Pharma, Yooma Wellness and...

European Cannabis Stocks Review: Akanda Dives Over 80% & Celadon Suffers After Reporting Huge Rise In Losses

This week was another difficult week for London Stock Exchange (LSE) listed cannabis companies, with every one of BusinessCann's tracked stocks reporting declines, including...

EU Cannabis Stocks Review: Love Hemp & Yooma Wellness Both See Their Shares Suspended

It has been another dramatic week on the global markets, with the Pound Sterling falling to a 2022-low and the NASDAQ registering its biggest...

EU Cannabis Stocks Review: Akanda’s Streak Comes To Abrupt End & Chill Brands New CEO Has His Work Cut Out To Recover Losses

This week was another difficult week for cannabis stocks across global markets, with a number of external factors seeing both the NASDAQ and LSE...

European Cannabis Stocks Review: FSA Makes ‘Final Call’ For Evidence As Cellular Goods’ Stock Recovers From Confusion Over Its Products’ Inclusion

THE fallout from the publication of the FSA's Public List is continuing to be felt on the stock markets this week, with the regulator...

What Is The Canpain Study And Will It Help Bring CBMPs Onto The NHS?

THE UK’s Health Research Authority (HRA) has approved the country’s first clinical study using cannabis flower for the treatment of chronic pain.  While the study,...

EU Cannabis Stocks Review: SEED Innovations Eurox Investment Bears Fruit, Akanda Continues To Climb & Intercure Posts Record Figures

Despite a number of positive announcements coming from the UK this week, British cannabis stocks failed to match the dramatic upswings experienced by their...

Over 340,000 Patients In Europe Set To Benefit From Medical Cannabis Access In 2022

NEW sales forecasts for the medical cannabis market in Europe predict that €353 million-worth of medical cannabis will be sold on the continent in...

EU Cannabis Stocks Review: Board Changes At Kanabo & Cellular Goods, Panaxia Stages Comeback & Akanda Continues Rally

European cannabis stocks had another generally positive week last week, with some major announcements from the North American market prop-up gains across the continent.  Mid-week...

EU Cannabis Stocks Review: Cellular Goods Stock Jumps 50% After Marketing Campaign Launch, SEED Innovations Enjoys Recovery, More from DeepVerge & Akanda

FOLLOWING a difficult few weeks for European cannabis stocks, last week saw many enjoy a recovery amid a flurry of positive announcements from both...

EU Cannabis Stocks Review: OCT Board Accused of Serious Governance Issues by Co-Founder, Panaxia’s Debt Pile Hits Stock & More from Love Hemp

AS European Cannabis stocks continue their battle against external market forces, it has been internal battles which made the headlines this week.  Major stakeholders of...

One Year After The First Cannabis Stocks Joined The LSE, Could We See A Fresh Run Of Cannabis IPOs This Year?

FEBRUARY 2022 marked the one-year anniversary of MGC Pharmaceuticals IPO on the London Stock Exchange, which saw cannabis stocks traded on the platform for the first time in its 320-year history. 

EU Cannabis Stocks Review: How Ukraine Crisis Is Impacting Cannabis Stocks, Chill Brands’ Revenue Could Be $1m Less & More From Tilray and MGC...

LAST week began with a number of European cannabis stocks levelling out following dramatic declines days earlier in reaction to Russia’s invasion of Ukraine.  While...

EU Cannabis Stocks Review: Stenocare Enters UK, Cellular Goods’ Sales Disappoint & Ukraine Crisis Hammers Stocks

The tragic developments in Ukraine hit global markets hard last week, and cannabis stocks even harder. As Europe’s worst fears were realised on Thursday...

EU Cannabis Stocks Review: OCT’s Co-Founder Demands Removal Of All 6 Directors – More from Akanda, MGC Pharmaceuticals & Apollon

We start this week's EU Cannabis Stocks Review with some breaking news from Oxford Cannabinoid Technologies, after the company's co-founder calls for a general meeting in an attempt enact a dramatic management overhaul.

EU Cannabis Stocks Review: Intercure Up 10% Amid Positive News From Israel, Ananda’s Progress Met With Share Dip, More From Cannovum, Chill Brands &...

As markets across Europe continue to be hammered by international tensions, gas price increases and a looming cost of living crisis, cannabis stocks largely...

Latest news

European Cannabis Stocks Review: SEED Innovations Shares Spike 25%, Futura Medical Signs Commercialisation Deal, & More From Akanda

AS quarterly and full-year results continued to be published across the global cannabis industry, European stocks enjoyed a relatively...

Creso Pharma Secures Heads of Agreement With Tattoo Aftercare Company Dr Pickles

Creso Pharma Limited (ASX:CPH, OTC:COPHF, FRA:1X8) (‘Creso Pharma’ or ‘the Company’) is pleased to advise it has signed anon-binding,...

LYPHE Group Poised For European Expansion As It ‘Steps Into Venture Capital’ With £5m Fundraise Led By Leafy Tunnel

LYPHE Group has announced the successful closure of its latest funding round, securing £5m in capital to fund expansion...

Must read

You might also likeRELATED
Recommended to you

Fall in Number Of UK Cannabis Users

ONE of the UK’s leading cannabis experts says the...

Fall in Number Of UK Cannabis Users

ONE of the UK’s leading cannabis experts says the...

Fall in Number Of UK Cannabis Users

ONE of the UK’s leading cannabis experts says the...